Better continence, erectile function, but data on oncologic outcomes still 2 years away ...

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

To identify imaging and clinical features that aid in distinguishing metastatic lesions from benign or physiologic uptake on PSMA PET, using correlation with scrotal ultrasound. This IRB-approved ...

Kinaxis® Inc. (“ Kinaxis ” or the “ Company ”) (TSX: KXS) today announces that, further to its previously announced intention to maximize the size of its normal course issuer bid (the “ NCIB ”), it ...

Treatment interruption guided by on-treatment prostate-specific membrane antigen (PSMA) PET/CT imaging in metastatic hormone-sensitive prostate cancer (mHSPC). This is an ASCO Meeting Abstract from ...

Abstract: Real-time ultrasound frame-to-volume registration overcomes the limited field of view inherent in intraoperative 2D ultrasound imaging, enabling comprehensive guidance for cardiac ...

A new study in Austria has shown that a special ultrasound treatment can effectively control early prostate cancer while helping men keep their quality of life. This method targets only the part of ...

An enlarged prostate is a big problem for men, no pun intended. According to Yale Medicine, about 50% of men between the ages of 51 and 60 have benign prostatic hyperplasia (BPH) or an enlarged ...

Radioligand therapy targeting prostate-specific membrane antigen (PSMA) has demonstrated promising clinical outcomes for patients with metastatic castration-resistant prostate cancer. However, ...

ABSTRACT: Objectives: To clarify the role of cervical ultrasound in the investigation and characterization of thyroid nodules and its predictive value for malignancy or benignity by searching for a ...